Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine trial begins for deadly elephant virus
Image (C) Shutterstock. 'Indali cools off the water, portraying fun and playfulness' - Chester Zoo.

Chester Zoo and the University of Surrey are collaborating on the trial. 

A vaccine trial for elephant endotheliotrophic herpesvirus (EEHV) has begun, as reported by BBC News.

Chester Zoo, in collaboration with scientists at the University of Surrey, has begun the process of trialling a vaccine for the deadly virus, which has killed seven of the zoo's Asian elephant calves. 

Formally characterised in 1999 by researchers at the Smithsonian Zoo, the virus has a mortality rate of up to 85 per cent, and by the time symptoms appear, it it often too late to intervene. 

Elephant keeper at Chester Zoo, Katie Morrison, told BBC News: "We've lost elephants usually between the ages of 18 months and three years," Katie explains. 

"When we see symptoms - lethargy, mouth lesions - it's usually too late. It's so tough - you do everything you can, and it's not enough.” 

The virus is believed to be passed from the older elephants to the calves, potentially when a calf is being weaned, when the antibodies from the mother's milk decline. Although there is still much unknown about the virus. 

Professor Falko Steinbach, from the University of Surrey, told BBC News: “We know it's almost impossible to prevent infection - we're trying to prevent serious disease and death.

“Our aim is to give them a prime before infection, so the elephant's immune system knows the virus and is on the front foot.

"We're using established, safe processes, and it's important to move ahead with a trial in elephants, because there is no other animal we can test this in."

Great progress has already been made by the team, with tests and blood donations from the herd able to diagnose the virus before symptoms appear. This success was demonstrated when Indali, a five-year old Asian elephant at Chester Zoo, tested positive for the virus.

Indali underwent extensive treatment with anti-virals, immune booster and blood plasma transfusions, and she recovered – the only calf to do so at Chester Zoo since 2010. 

As the BBC has reported, Professor Steinbach is hopeful that significant progress will be made towards a vaccine within five years' time. 

 

Image (C) Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.